5 Best Pharmaceutical Stocks to Invest In

3. Pfizer Inc. (NYSE: PFE)

Number of Hedge Fund Holders: 67

Pfizer Inc. (NYSE:PFE) is an American pharmaceutical company developing and manufacturing drugs in several medical fields such as oncology and endocrinology. Along with the German biotech company BioNTech SE (NASDAQ:BNTX), it developed one of the earliest Covid-19 vaccines. It is ranked third on our list of 15 best pharmaceutical stocks to invest in. The stock has returned over 31.47% to investors over the course of the past year.

On July 28, Pfizer Inc. (NYSE:PFE) posted earnings for the first quarter of 2021, reporting earnings per share of $1.07, beating estimates by $0.09. The revenue over the period was around $18.98 billion, up 60.81% year-over-year.

At the end of the second quarter of 2021, 67 hedge funds in the database of Insider Monkey held stakes worth $2.4 billion in Pfizer Inc. (NYSE:PFE), up from 65 funds in the preceding quarter.

Out of the hedge funds being tracked by Insider Monkey, Diamond Hill Capital has the most valuable stake in Pfizer Inc. (NYSE:PFE) as of the end of the second quarter of 2021, worth $457.4 million, comprising 1.73% of its total 13F portfolio. Diamond Hill Capital increased its stake in Pfizer Inc. (NYSE:PFE) by 4% to around $457 million. This follows an increase of 23% during the first quarter of 2021.